Stay updated on JNJ-67856633 in NHL & CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.

Latest updates to the JNJ-67856633 in NHL & CLL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the page, and the previously displayed government funding lapse notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site notice about a lapse in government funding and the page revision label was updated to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedA glossary toggle was added; the footer now includes updated QC-related labels—'Last Update Submitted that Met QC Criteria', 'No FEAR Act data'—and a new 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3 label. This is a metadata update and does not change study details.SummaryDifference0.0%

- Check64 days agoChange DetectedA new Locations section has been added and the state location headings (California, Nebraska, New York, Texas) have been reorganized under it; the old location sections and the HHS Vulnerability Disclosure link were removed, and the page revision updated to v3.3.3.SummaryDifference0.4%

- Check85 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page. The study details and layout appear unchanged.SummaryDifference0.0%

Stay in the know with updates to JNJ-67856633 in NHL & CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.